• TRADE NAMES: Cymevan; Cymeven; Cymevene; Cytovene (Roche); Vitrasert
  • INDICATIONS: Cytomegalovirus retinitis in immunocompromised patients
  • CLASS: Antiviral, Guanine nucleoside analog
  • HALF-LIFE: 2.5–3.6 hours
  • See adverse reactions attributed to class:

    Antiviral

GRANULOCYTOPENIA, ANEMIA AND THROMBOCYTOPENIA

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 10/07/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric